Monday, January 31, 2022

New drug approvals: Ripretinib for advanced gastrointestinal stromal tumors (GIST) in fourth or later-line therapy

xlomafota13 shared this article with you from Inoreader

Bull Cancer. 2022 Jan 27:S0007-4551(22)00017-0. doi: 10.1016/j.bulcan.2022.01.002. Online ahead of print.

NO ABSTRACT

PMID:35094842 | DOI:10.1016/j.bulcan.2022.01.002

View on the web

No comments:

Post a Comment

Collaboration request

Hi there How would you like to earn a 35% commission for each sale for life by selling SEO services Every website owner requires the ...